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Summary 
Agonist binding to the inhibitory glycine receptor 
(GlyR) initiates the opening of a chloride-selective 
channel that modulates the neuronal membrane po- 
tential. Point mutations of the GlyR, substituting Arg- 
271 with either Leu or Gin, have been shown to under- 
lie the inherited neurological disorder startle disease 
(hyperekplexia). We show that these substitutions re- 
sult in the redistribution of GlyR single-channel con- 
ductances to lower conductance levels. Additionally, 
the binding of the glycinergic agonists I$-alanine and 
taurine to mutated GlyRs does not initiate a chloride 
current, but instead competitively antagonizes cur- 
rents activated by glycine. These findings are consis- 
tent with mutations of Arg-271 resulting in the uncou- 
pling of the agonist binding process from the channel 
activation mechanism of the receptor. 
Introduction 
Fast synaptic neurotransmission in the mammalian ner- 
vous system is mediated by the ligand-gated ion channel 
(LGIC) class of neurotransmitter receptors, which includes 
the receptors for acetylcholine, serotonin, y-aminobutyric. 
acid, and glycine (Grenningloh et al., 1987; Schofield et 
al., 1987; Maricq et al., 1991). LGICs are composed of 
five subunits arranged in the postsynaptic membrane to 
form a central ion channel. Each subunit consists of a 
large, N-terminal extracellular domain and four transmem- 
brahe domains (M1-M4). The agonist-binding sites and 
the ion channel of LGIC receptors are physically distinct 
(Unwin, 1993; Valenzuela et al., 1994). In the glycine re- 
ceptor (GlyR), the agonists glycine, 13-alanine, and taurine 
bind to sites in the N-terminal extracellular egion (Kuhse 
et al., 1990; Vandenberg et al., 1992; Schmieden et al., 
1992, 1993), thereby initiating the rapid opening of a chlo- 
ride-selective channel formed by the transmembrane do- 
mains (Grenningloh et al., 1987). Although the agonist 
binding and ion permeation processes of the GlyR and 
other LGIC receptors have been described in increasing 
detail (Sieghart, 1992; Vandenberg and Schofield, 1993; 
Devillers-Thiery et al., 1993), little is known of the mecha- 
nism linking these two events. 
Point mutations of the GlyR ~1 subunit have recently 
been shown to underlie the autosomal dominant neurolog- 
ical disorder startle disease, or hyperekplexia (Kirstein and 
Silfverskiold, 1958; Suhren et al., 1966; Andermann and 
Andermann, 1988; Shiang et al., 1993). This disease re- 
sults in muscular hypertonia and an exaggerated startle 
response to sensory stimuli (Kirstein and Silfverskiold, 
1958; Suhren et al., 1966; Andermann and Andermann, 
1988). GlyR ~xl subunits containing startle disease point 
mutations substituting Leu or Gin for Arg-271 (Shiang et 
al., 1993) display dramatic 230- to 410-fold reductions in 
the glycine-activated current sensitivity (Rajendra et al., 
1994). The finding that Arg-271 is a highly specific determi- 
nant of glycine activation is unexpected because of its 
location at the extracellular border of the channel-lining 
M2 transmembrane domain rather than in the N-terminal 
extracellular egion. We now show that mutation of Arg- 
271 transforms the glycinergic agonists 13-alanine and tau- 
rine into competitive antagonists. This transformation is 
consistent with the uncoupling of the agonist-binding and 
channel-opening events within the GlyR. Arg-271 is thus 
a critical element for the transduction of agonist binding 
into channel activation in at least one member of the LGIC 
class of neurotransmitter receptors. 
Results 
Site-directed mutagenesis was used to replace Arg-271 
with either Leu (R271 L) or Gin (R271Q) in the human GlyR 
~1 subunit cDNA (Grenningloh et al., 1990). Transfection 
of the cDNA into human embryonic kidney 293 cells re- 
sulted in the expression of homomeric al  subunit GlyRs, 
which were subsequently examined using patch-clamp 
techniques (Hamill et al., 1981) and [3H]strychnine binding 
assays. Mutation of Arg-271 to Leu or Gin produced a 230- 
to 410-fold reduction in the sensitivities of glycine- 
activated currents (Rajendra et al., 1994). Glycine was 
therefore used at 50 mM to elicit maximal currents in the 
mutant GlyRs, and at 1 mM in the wild-type (WT) GlyRs 
(Figure 1A). Both the rate and extent of decay of maximal 
currents were reduced in the mutant GlyRs as compared 
with WT GlyRs (Figure 1A), and the magnitudes of maxi- 
mal glycine-activated currents were also considerably 
smaller (Figure 1B). The extent of current decay was in- 
versely correlated to current size in WT GlyRs (Pearson 
correlation, n = 10, r -- -0.78, p -- 0.008). For currents 
elicited by 1 mM glycine, the ratio of the current size at 
10 s to the current size at 1 s was 0.84 when the peak 
current was 0.4 nA, but only 0.34 for an 8.0 nA peak cur- 
rent. The size and extent of decay of currents were not 
strongly correlated in either R271L GlyRs (Pearson corre- 
lation, n = 8, r -- 0.22, p = 0.59) or R271Q GlyRs (Pearson 
correlation, n = 8, r = -0.39, p = 0.34). Thus, the reduced 
current decay in the mutant GlyRs may be attributed 
largely to the absence or diminishment of a chloride shift 
effect (Akaike et al., 1987; Cascio et al., 1993). 
The decreased current sizes in cells expressing the mu- 
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Figure 1. Agonist-Activated Currents in WT and Mutant GlyRs 
(A) Currents elicited by application of glycine, I~-alanine, and taurine 
in cells expressing WT, R271 L, and R271Q GlyRs. Vertical calibration 
values are in nanoamperes; horizontal calibration bars are 2 s. Num- 
bers above traces are the millimolar concentrations of the applied 
agonists. 
(B) Mean maximal current values with SEM for cells expressing WT 
(n = 15), R271L (n = 37), and R271Q (n = 43) GlyRs. Maximal 
currents in both mutant GlyRs were significantly smaller than those 
in WT GlyRs (unpaired t tests, p < .0001). 
(C) Br,~ values with SEM for [3H]strychnine binding isotherms in cells 
expressing WT and mutant GlyRs. 
(D) Mean normalized current values with SEM for cells expressing WT 
and mutant GlyRs. The normalized current was obtained by dividing 
the mean maximal current by the Bmax value, then standardizing values 
to the WT GlyR value. 
tant GlyRs were not caused by a reduction in the numbers 
of expressed receptors (Br, ax). Indeed, the mutant GlyRs 
showed up to 3-fold higher receptor numbers per cell than 
WT GlyRs (Rajendra et al., 1994) (Figure 1C). This sug- 
gests that the relative decrease in current through the mu- 
tant GlyRs is even more pronounced at the single-channel 
level (Figure 1D). Single-channel measurements were 
made from outside-out patches to ascertain whether the 
reduction was due to changes in the single-channel con- 
ductance. At a holding potential of -55  mV, application 
of 0.1-10 I~M glycine to WT GlyRs or 0.1-10 mM glycine 
to the mutant GlyRs elicited single-channel currents that 
reversed direction close to 0 mV, the expected equilibrium 
potential for chloride. In WT GlyRs, conductance states 
(and frequency of occurence) of 88 pS (51 O/o), 68 pS (36%), 
49 pS (4%), and 30 pS (9%) were seen (Figure 2A). Their 
size and distribution correspond to those reported in pre- 
vious studies demonstrating multiple conductance states 
in single (zl homomeric GlyR channels (Takahashi et al., 
1992; Bormann et al., 1993). However, the distributions 
of conductance states in mutant GlyRs were markedly dif- 
ferent. In R271L GlyRs, conductance states of 63 pS 
(14%), 47 pS (33%), 29 pS (25%), and 16 pS (28%) were 
observed (Figure 2B). R271Q GlyRs displayed only a sin- 
gle 18 pS conductance state (Figure 2C). Thus, reduced 
elementary conductances contribute significantly to the 
decreases in whole-cell, glycine-activated currents in cells 
expressing the mutant GlyRs. 
In WT GlyRs, application of 2 mM 13-alanine or 10 mM 
taurine was sufficient to elicit maximal currents (Figure 
1A). However, application of either agonist at concentra- 
tions up to 100 mM failed to elicit any current flow in either 
of the m utant GlyRs (Figure 1A). To determ ine whether this 
abolition of current was due to the absence of 13-alanine or 
taurine binding to the mutant GlyRs, [3H]strychnine dis- 
placement assays were performed (Figure 3). Whereas 
the apparent glycine binding affinities (Ki values) in the 
mutant GlyRs were reduced 50-to 100-fold with respect 
to the WT GlyR, the apparent binding affinities of 13-alanine 
and taurine were reduced only 4- to 12-fold (Table 1 ; Fig- 
ure 3). Consequently, 13-alanine and taurine bind to the 
mutant GlyRs with higher affinities than glycine (Table 1; 
Figure 3). 
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Figure 2. Conductance States of WT and Mutant GlyRs 
Histograms display the distribution of amplitudes of single-channel currents recorded at -55 mV from three (A) or four (B and C) outside-out 
patches. Numbers above the fitted Gauss functions (curves) are the values of the derived conductance states in picosiemens, represented by the 
horizontal dotted lines across single-channel current traces in insets. Current traces were filtered at 0.5 or 1 kHz for display. For WT GlyRs (A), 
elementary conductances were (with frequency of occurrence) 88 pS (51O/o), 68 pS (36O/o), 49 pS (4%), and 30 pS (90/0). For R271L GlyRs (B), 
conductances were 63 pS (14%), 47 pS (33%), 29 pS (25%), and 16 pS (28%). R271Q GlyRs (C) displayed a single 18 pS conductance state. 
Vertical bars, 5 pA; horizontal bars, 50 ms (A and B), 500 ms (C). 
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Figure 3. Glycine, ~-Alanine, and Taurine Displacement Curves of 
Bound [3H]Strychnine from 293 Cells Expressing WT and Mutant 
GlyRs 
Data represent the mean values with SEM of triplicate measurements 
from a representative experiment. 
The effects of I5-alanine and taurine binding on currents 
elicited by glycine binding to the mutant GlyRs were stud- 
ied by simultaneously applying either 13-alanine or taurine 
with glycine. In WT GlyRs, coapplication of up to 100 mM 
13-alanine or taurine did not alter the current elicited by 
1 mM glycine (Figure 4A). In the mutant GlyRs, however, 
currents elicited by 50 mM glycine were reduced in a dose- 
dependent manner upon coapplication of either 13-alanine 
or taurine and were virtually abolished upon coapplication 
of 100 mM 13-alanine or taurine (Figure 4). To determine 
whether this antagonism was competitive or noncompeti- 
tive, the dose-response curves of glycine-activated cur- 
rents, obtained by application of glycine alone, were com- 
pared with those obtained upon coapplication of 1 mM 
I~-alanine or taurine (Figure 5A). For R271L and R271Q 
GlyRs, coapplication of 1 mM 13-alanine produced 3.3- to 
3.5-fold increases in the ECso for glycine without affecting 
the values of maximal glycine-activated currents (Ira,x; Fig- 
Table 1. Ki Values for Displacement of Bound [3H]Strychnine 
by Glycine, ~-Alanine, and Taurine in 293 Cells 
Expressing WT and Mutant GlyRs 
Ki (mM) 
GlyR Glycine [5-Alanine Taurine 
WT 0.096 _4- 0.012 0.13 _ O.01 0.20 _ 0.02 
(I) (i) (I) 
R271L 4.8 _+ 0.7 1.5 _ 0.3 1.2 _ 0.1 
(50) (12) (6) 
R271Q 9.6 -.+ 1.9 1.4 - 0.1 0.82 - 0.07 
(100) (11) (4) 
Mean values and SEM from five independent determinations for gly- 
cine and three to four independent determinations for 13-alanine and 
taurine are shown. The values in parentheses are the -fold changes 
relative to the values for the WT GlyR. 
ure 5A). Similarly, coapplication of taurine to R271L and 
R271Q GlyRs caused 3.1- to 3.6-fold increases in the ECs0 
for glycine without altering Im~x (Figure 5A). These reduc- 
tions in glycine sensitivity without an alteration in the size 
of maximal currents are characteristic of competitive an- 
tagonism. Application of 1 I~M strychnine or 100 I~M picro- 
toxin alone did not elicit currents from either R271L or 
R271Q GlyRs (n = 5), indicating that neither of these com- 
petitive antagonists of the GlyR had been converted to 
agonists. Indeed, these concentrations abolished to<10% 
maximal glycine-activated currents in both WT and mutant 
GlyRs (n = 5; data not shown). Thus, the mutations of 
Arg-271 transform agonists into competitive antagonists, 
but not competitive antagonists into agonists. 
To determine whether the binding of 13-alanine or taurine 
to the mutant GlyRs resulted in the desensitization of the 
receptor, the recoveries of glycine-activated currents elic- 
ited subsequent o a conditioning application of either gly- 
cine, 13-alanine, or taurine were compared (Figure 5B). Gly- 
cine-activated currents elicited 5 s after a 20 s conditioning 
application of 100 mM glycine were 38% and 43% of the 
size of control currents elicited in the absence of a condi- 
tioning pulse for R271 L and R271Q GlyRs, respectively. 
This result demonstrates that a significant proportion of 
the mutant GlyRs remained in the desensitized state. In 
contrast, the size of currents elicited 5 s after a 20 s condi- 
tioning application of 100 mM 13-alanine or taurine did not 
differ substantially from those elicited in the absence of 
the conditioning application. Relative current sizes were 
93% and 92% for 13-alanine and taurine, respectively, for 
R271L GlyRs, and 90% for both I~-alanine and taurine for 
R271Q GlyRs (Figure 5B). Hence, receptor desensitiza- 
tion caused by binding of I~-alanine and taurine does not 
underlie their antagonism of glycine-activated currents. 
Discussion 
In the GlyR and other LGICs, agonist binding initiates the 
transition of the receptor from a nonconducting (closed) 
state to a conducting (open) state. The prolonged pres- 
ence of bound agonist produces a further transition to a 
nonconducting, desensitized state. The Hill coefficients 
for glycine-activated currents in both WT and mutated 
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Figure 4. Inhibition of Glycine-Activated Currents by J3-Alanine and 
Taurine in 293 Cells Expressing the Mutant GlyRs 
(A) Effect of coapplication of 0, 0.1, 1, t0, or 100 mM ~-alanine on 
currents elicited by 1 mM ONE GlyR) or 50 mM (R271L and R271Q 
GlyRs) glycine. Vertical calibration values are in nanoamperes. Hori- 
zontal calibration bars are 2 s. 
(13) Dose dependence of inhibition of glycine-activated currents from 
coapplication with ~-alanine and taurine. Glycine concentrations are 
1 mM (WT GlyR) or 50 rnM (R271L and R271Q GlyRs). Current values 
are relative to the current value elicited by glycine alone. Data repre- 
sent mean values with SEM from three cells. 
GlyRs are greater than 1 (Rajendra et al., 1994), sug- 
gesting that at least two agonist molecules are required 
to activate the GlyRs. A minimal scheme describing the 
progression from agonist binding to channel activation and 
receptor desensitization is 
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Figure 5. Mechanism of Glycine Inhibition by ~-Alanine and Taurine 
(A) Dose-response curves of currents elicited by application of glycine 
alone or coapplication of 1 mM p-alanine to a cell with R271Q GlyRs 
(left) or 1 mM taurine to a cell with R271L GlyRs (right). For each 
mutant GlyR, similar eductions in current sensitivity were observed 
in three cells for 13-alanine and three cells for taurine. 
(B) Effects of prior application of glycine, ~-alanine, and taurine on 
glycine-activated currents in a cell expressing R271 L GlyRs. All traces 
are from the same cell. A prior 20 s conditioning application of 100 mM 
glycine substantially reduces the current elicited by 100 mM glycine 
5 s later (left trace). Currents elicited by 100 mM glycine 5 s after a 
20 s application of either 100 mM ~-alanine (middle trace) or 100 mM 
taurine (right race) are similar in size to that elicited by the conditioning 
application of glycine (left race). Similar esults were observed in three 
cells expressing each mutant GlyR. 
1 2 3 4 
Rc *-~ ARc *-~ A2Rc *-* A2Ro ~ A2RD 
where A is the agonist (A2 referring to two agonist mole- 
cules being bound), and Rc, Ro, and RD represent the 
receptor in closed, open, and desensitized states, respec- 
tively. Whereas this progression is completed by glycine 
in the mutant GlyRs, ~-alanine and taurine initiate step 1, 
and possibly step 2, but not step 3, which would elicit a 
current. Thus, the normal transition of the receptor from 
the closed to open state upon I~-alanine and taurine bind- 
ing has been prevented by mutation of Arg-271. The com- 
petitive antagonism of glycine by 13-alanine and taurine 
arises from their competition for the single- and/or double- 
agonist bound states arising from steps 1 and 2. 
The sizes of both whole-cell, glycine-activated currents 
(Figure 1) and single-channel conductances (Figure 2) 
were reduced in the mutant GlyRs. This finding is similar 
to that of a mutational study of analogous residues of nico- 
tinic acetylcholine receptor (nAChR) subunits (Imoto et al., 
1988) and is consistent with Arg-271's positive charge and 
location at the extracellular border of the receptor channel 
(Grenningloh et al., 1987; Langosch et al., 1991, 1993). 
However, we found no obvious change in either the rela- 
tive anion-cation selectivities or the shapes of current- 
voltage relations of whole-cell currents through R271 L and 
R271Q GlyRs (Rajendra et al., 1994). Also, it is unclear 
whether the redistribution of channel conductances to 
lower levels that we report here fully accounts for the dimin- 
ishment of whole-cell currents, and it is possible that al- 
tered channel kinetics also contribute, The single-channel 
traces in Figure 2 (note longer time scale for [C]) suggest 
that the mutant GlyRs may exhibit longer channel open 
times and channel bursting. These changes may explain 
the increased sustained component and reduced extent 
of decay of whole-cell currents through the mutant GlyRs 
(Figure 1; Figure 4; Figure 5). 
The values of the three largest conductance states of 
R271L GlyRs correlate closely with the three smallest 
states ofWT GlyRs (Figure 2). Furthermore, the 16 and 18 
pS conductance states seen in R271 L and R271Q GlyRs, 
respectively, may correspond to an infrequent 18 pS state 
reported in al  homomeric GlyRs (Bormann et al., 1993). 
It is unlikely that the 63, 47, and 29 pS conductance states 
seen in R271L GlyRs are the summation of 2, 3, or 4 of 
the 16-18 pS conductances seen in both mutant GlyRs, 
since we frequently observed direct transitions of the 
closed state to or from one of these higher states (Figure 
2). The mutations of Arg-271 may therefore prevent or 
impair transitions of the channel to one or more conducting 
conformations. These transitions are collectively repre- 
sented by step 3 in the scheme above, the same step that 
is abolished for I~-alanine and taurine in themutant GlyRs. 
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The redistribution of glycine-activated conductances to 
lower levels in the mutant GlyRs may thus be an intermedi- 
ate manifestation of the same mechanism that prevents 
channel activation by ~-alanine and taurine. However, the 
reductions in the apparent binding affinity for glycine were 
an order of magnitude or more higher than the 4- to 12-fold 
reductions for I~-alanine and taurine (Rajendra et al., 1994) 
(Table 1; Figure 3), suggesting that mutations of Arg-271 
may have impaired the binding site for glycine but not 
13-alanine or taurine. The different effects exerted by these 
mutations on glycine as compared with ~-alanine or tau- 
rine may be due to the noncongruence of the binding sites 
for these competitive agonists (Kuhse et al., 1990; Van- 
denberg et al., 1992; Schmieden et al., 1992, 1993). After 
submission of this manuscript, Langosch et al. (1994) re- 
ported on a study of the same mutations of Arg-271. Their 
report, which confirms our earlier finding that these muta- 
tions reduce the glycine sensitivity of the GlyR (Rajendra et 
al., 1994), describes similar changes in glycine-activated 
single-channel conductances. 
By uncoupling the event of agonist binding from that 
of channel opening, the startle disease mutations have 
identified Arg-271 as a critical element of the signal trans- 
duction mechanism of the GlyR. Cysteine residues affect- 
ing channel gating have been identified in the M1 and M4 
regions of nAChR subunits (Lo et al., 1991; Li et al., 1992; 
Lee et al., 1994). In contrast to our findings, mutation of 
these residues increases macroscopic currents, as would 
be consistent with an impairment of the channel-closing 
mechanism (Lo et al., 1991; Li et al., 1992; Lee et al., 
1994). In the nAChR, mutations of Tyr-190, Tyr-198, and 
Asp-200, located in an agonist-binding domain in the 
N-terminal extracellular egion of the a subunit (Tomaselli 
et al., 1991), transform partial agonists into antagonists 
(O'Leary and White, 1992). That the alteration of an ago- 
nist-binding domain impairs channel gating is not unex- 
pected owing to the reciprocity of these two processes 
(Amin and Weiss, 1993; Colquhoun and Farrant, 1993). A 
similar explanation does not easily account for the effects 
arising from mutation of Arg-271, since, as reasoned ear- 
lier, this residue does not appear to be directly involved 
in 13-alanine or taurine binding. Mutation of a leucine resi- 
due in the nAChR channel region achieves the converse 
effect of transforming competitive antagonists into ago- 
nists by converting a high affinity, nonconducting, desensi- 
tized state into a conducting state (Bertrand et al., 1992). 
It is unlikely that a similar mechanism underlies the effects 
we report, since the binding of 13-alanine or taurine does 
not cause desensitization in the mutant GlyRs (Figure 5C). 
Also, application of the competitive glycinergic antago- 
nists picrotoxin (Lynch et al., unpublised data) and strych- 
nine did not induce currents. The decay of whole-cell, gly- 
cine-activated currents is altered in the mutant GlyRs 
(Figure 1; Figure 4; Figure 5). Diminished chloride shift 
effects (Akaike et al., 1987; Cascio et al., 1993) appear 
to be responsible, at least in part, since WT GlyR currents 
of sizes comparable to those of mutant GlyRs also show 
a similarly reduced decay (see Figure 1 in Rajendra et al., 
1994). Nevertheless, altered desensitization kinetics in the 
mutant GlyRs may also contribute. 
That the distinction between agonism and antagonism 
resides in the nature of a single residue provides an im- 
portant clue as to the mechanisms of action of these two 
classes of ligands. The simplest explanation is that Arg- 
271 is crucial for the integration of information from ago- 
nist- and antagonist-binding sites and the subsequent 
transmission of an appropriate signal to the activation gate 
of the channel. 
Experimental Procedures 
Site-Directed Mutagenesis 
The cDNA encoding the (~1 subunit of the human glycine receptor 
(Grenningloh et al., 1990) was subcloned into the pCIS expression 
vector (Gorman et al., 1990). Mutations in the cDNA were constructed 
using the oligonucleotide-directed polymerase chain reaction muta- 
genesis method of Ho et al. (1989) and were confirmed by sequencing 
the cDNA clones. 
Expression of Mutated GlyR el Subunit cDNAs 
Plasmid DNA encoding WT or mutated ~1 subunits of the human 
glycine receptor was transfected using the method of Chen and Okay- 
area (1987) into exponentially growing 293 cells (adenovirus trans- 
formed human embryonic kidney cells; ATCC CRL 1573; Sontheimer 
et al., 1989; Gorman et al., 1990). After 24 hr, the cells were washed 
twice with culture medium (Eagle's minimum essential medium in 
Hanks salts supplemented with 2 mM glutamine and 10% fetal calf 
serum) and refed. Intact cells were used for electrophysiologicsl exami- 
nation or harvested 48 hr after transfection for [3H]strychnine binding 
assays. 
Electrophysiological Measurements 
Following transfetion (48 hr), cells were patch clamped in the whole-cell 
mode or outside-out, excised-patch configuration (Hamill et al,, 1981) 
at a holding potential of -55 mV while being continually superfused 
with a bath solution containing 140 mM NaCI, 10 mM glucose, 5 mM 
KCI, 2 mM CaCI2, 2 mM MgCI2, and 10 mM HEPES (pH 7.4). Glycine, 
~-alanine, or tauri ne dissolved in th is solution was rapidly applied to the 
chamber using a microperfusion tube system. No significant osmotic 
effects were observed, even at 100 mM agonist concentrations (Fig- 
ures 1A; Figure 5). Voltages were corrected for junction potentials 
using the JPCalc program (Barry, 1994). The pipette solution contained 
145 rnM CsCI, 2 mM CaCI2, 2 mM MgCI2, 10 mM HEPES, and 10 mM 
EGTA (pH 7.4). Dose-response data for glycine-activated currents in 
individual cells were fitted using a nonlinear least squares algorithm 
to the Hill equation: I/1~,~ = [G]h/(ECso" + [G]h), where I is the magnitude 
of the peak current elicited by a concentration [G] of glycine, Im~ is 
the magnitude of the maximum peak current elicited by saturating 
concentrations of glycine, ECso is the value of [G] required to elicit a 
half-maximal peak current, and h is the Hill coefficient. Currents from 
outside-out patches were stored digitally at a sampling rate of 4 kHz 
and filtered at 1 kHz before analysis using pCLAMP software (Axon 
Instruments, Foster City, CA). 
[3H]Strychnine Binding Assays 
Transfected cells were incubated with [3H]strychnine (1-50 nM; 24.5 
Ci/mM; New England Nuclear) with or without 10 pM cold strychnine 
to determine nonspecific binding. After incubation to equilibrium at 
4°C for 60 min, cells were collected by rapid filtration onto Whatrnan 
GF/B filter paper, and the amount of radioactive strychnine remaining 
bound was determined. The I~ and Bm~ for the [3H]strychnine satura- 
tion isotherms and IC~0 and Ki for glycine, I~-alanine, and taurine dis- 
placement of bound [3H]strychnine were estimated using the InPIot 
program (Graph Pad Software, San Diego, CA). 
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